Physician profile

Robert Koe

Internal Medicine · Orange Park, FL

NPI 1609091081

$2,253.68

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$20.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $992.89 2019-2021
Glaxosmithkline, LLC. $469.81 2019
Novo Nordisk INC $309.83 2019
Stryker Corporation $114.65 2019
Boston Scientific Corporation $97.21 2019
Becton, Dickinson and Company $93.00 2022
Lilly USA, LLC $85.58 2019
Amarin Pharma, INC. $31.17 2019
Bayer Healthcare Pharmaceuticals INC. $20.00 2024
Astellas Pharma US INC $15.42 2019
Pfizer INC. $12.27 2019
Astrazeneca Pharmaceuticals Lp $11.85 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Koe

$2,253.68

in general payments reported 2019-2025

Years
2019-2024
Top company
Janssen Pharmaceuticals, INC

https://glasscript.com/doctor/344810/robert-koe

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.